Cardinal Health Stock Intrinsic Value – Cardinal Health Poised for Success in 2024
December 22, 2023
☀️Trending News
Cardinal Health ($NYSE:CAH) is preparing to be one of the most successful companies in 2024. With a focus on strategic, forward-thinking investments and initiatives, the company is positioning itself for success. The company’s focus on innovation has allowed them to remain relevant in an ever-changing industry. In an effort to stay ahead of the competition, Cardinal Health has invested in cutting-edge technologies and healthcare solutions that will contribute to their success in 2024. From advancing digital solutions to improving their drug supply chain, Cardinal Health is taking steps to ensure their future success. Cardinal Health is also committed to creating an impactful and positive environment for its employees. The company offers programs such as professional development and wellness initiatives that are designed to keep their employees satisfied and motivated.
Additionally, Cardinal Health is actively expanding its network of partners to help their customers reach their goals. All of these efforts are positioning Cardinal Health for success in 2024 and beyond. From an expansive network of partners and innovative solutions to a commitment to employee satisfaction, Cardinal Health is strategically taking the steps needed to remain competitive in the healthcare industry.
Price History
Cardinal Health, one of the leading healthcare services and products companies worldwide, is poised for success in 2024. On Thursday, the company’s stock opened at $99.8 and closed at $101.2, signaling a 2.1% increase from the previous closing price of 99.1. This is a strong indication that the market is confident in the company’s ability to deliver strong financial performance in the coming years.
As it stands, Cardinal Health is well-positioned to capitalize on current trends in the healthcare industry, such as the shift towards telehealth and digital health services, as well as the increased demand for generic drugs. It remains to be seen how these trends will impact the company’s bottom line, but analysts are optimistic that Cardinal Health will continue to remain a force in the industry. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Cardinal Health. More…
| Total Revenues | Net Income | Net Margin |
| 210.17k | 156 | 0.6% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Cardinal Health. More…
| Operations | Investing | Financing |
| 3.36k | -447 | -2.55k |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Cardinal Health. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 43.71k | 47.2k | -14.17 |
Key Ratios Snapshot
Some of the financial key ratios for Cardinal Health are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 10.8% | 2.5% | 0.3% |
| FCF Margin | ROE | ROA |
| 1.4% | -11.5% | 0.8% |
Analysis – Cardinal Health Stock Intrinsic Value
At GoodWhale, we have conducted an in-depth analysis of CARDINAL HEALTH‘s wellbeing. Our proprietary Valuation Line has assessed the fair value of CARDINAL HEALTH’s share to be around $83.3. Currently, CARDINAL HEALTH stock is traded at $101.2, indicating an overvaluation of 21.5%. We highly recommend investors to take this into account before making any investment decisions. More…
Peers
Its competitors are AmerisourceBergen Corp, McKesson Corp, and Sigma Healthcare Ltd.
– AmerisourceBergen Corp ($NYSE:ABC)
AmerisourceBergen Corp is a drug wholesaler that was founded in 1985. The company has a market cap of 32.4B as of 2022 and a return on equity of 417.0%. AmerisourceBergen Corp distributes prescription drugs and other healthcare products and services to healthcare providers and pharmaceutical companies. The company operates in two segments, Pharmaceutical Distribution and Other.
– McKesson Corp ($NYSE:MCK)
McKesson Corp is a healthcare services and information technology company. It has a market cap of 55.96B as of 2022 and a Return on Equity of -74.43%. The company provides a range of services and products to healthcare providers, payers, and consumers. These services and products include prescription drugs, medical supplies, and software and technology solutions.
– Sigma Healthcare Ltd ($ASX:SIG)
Sigma Healthcare Ltd is a pharmaceutical company with a market cap of 683.23M as of 2022 and a ROE of 0.46%. The company manufactures and distributes a range of prescription and over-the-counter medicines, medical devices, and other healthcare products.
Summary
Cardinal Health is a leading healthcare services provider, with a focus on delivering high quality products and services to their customers. Cardinal Health has also been investing in its operations to increase efficiency and cost savings. In light of these developments, many analysts agree that Cardinal Health is poised for a successful 2024, and could be an attractive investment opportunity for long-term investors.
